CClinicalTrials.gg
CompletedNCT02964156Updated Nov 16, 2016

Effect of a Thin Customized Insole in RA

An interventional study of Supersole and No intervention in Rheumatoid Arthritis, sponsored by Revmatismesykehuset AS. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-11-16.

Sponsored by Revmatismesykehuset AS · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

50-90% of patients with RA reports foot problems and the metatarsophalangeal joints of the forefoot are most frequently afflicted. Studies shows that foot problems can influence negatively on the walking function, physical activity and quality of life. Different foot orthoses and insoles are used as an intervention. Studies find that different insoles do have effect on pain, but there are no or minor effect on walking ability. The literature reports a further need for research and indicates the importance of studies on the effects of cost-effective insoles for patients with RA.

Custom-built insoles takes time and are often expensive, and many patients, especially women, do not wear them since they often do not fit the shoes they prefer to wear. In this study, a 4-mm thin, flat insole of a malleable plastic material (CI-Core®) with synthetic textile material on the upper side is customized to provide support for the transverse and longitudinal arches of the foot to reduce pressure on painful joints. The insole is easily customized and ready for use the same day. The purpose of this study was to determine whether this insole can reduce foot pain and increase walking distance in patients with RA and forefoot pain.

An experimental study was performed on patients with RA and forefoot pain in either one or both feet. The patients walked as fast as they could in 6 minutes (6MWT) with either insoles (situation A) and without insoles (situation B). The order of situation A and B was randomized, and the assessor was blinded for the order of the two situations. Both tests were conducted the same day. After each test round, the patient was asked to register pain in the foot and perceived exertion. A telephone interview was conducted one year after the effect study to examine whether the insoles were still being used.

02

Conditions studied

  • Rheumatoid Arthritis

Keywords

  • RA
  • Insole
  • Forefoot
  • Walking Ability
  • Pain
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 21 is below the median of 90 across 2,377 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Revmatismesykehuset AS is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis Rheumatoid Arthritis
  • Foot pain while walking
  • Positive Gaenslens sign in forefoot
  • Native Norwegian speaking

Exclusion criteria

Exclusion Criteria:

  • Cognitive dysfunction
  • Problems reading
  • Problems in walking due to problems han the foot such as in ankel, knee or hip
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Walking test using insoles

    Supersole

    Other: Supersole

  • Experimental
    Walking test not using insoles

    no intervention

    Other: No intervention

Interventions

  • OtherSupersole

    A 4-mm thin, individually customized insole of a malleable plastic material (CI-Core®) with synthetic textile material on the upper side.

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Pain intensity measured using Visual Analog Scale (VAS)

    Pain is measured using Visual Analog Scale (VAS)

    Time frame: Change between test situation A and B (or B and A). A: Walking test using insoles. B. Walking test not using insoles. There is a 20 minute break between the two situations.

  2. Walking ability measured using the 6-minute walking test

    Walking ability is measured using the 6-minute walking test

    Time frame: Change between test situation A and B (or B and A). A: Walking test using insoles. B. Walking test not using insoles. There is a 20 minute break between the two situations.

Secondary outcomes

  1. perceived exertion measured using Borg CR10 scale

    Perceived exertion is measured using Borg category ratio scale (Borg CR10)

    Time frame: Change between test situation A and B (or B and A). A: Walking test using insoles. B. Walking test not using insoles. There is a 20 minute break between the two situations.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02964156
Lead sponsor
Revmatismesykehuset AS
Responsible party
Sponsor
First posted
Nov 16, 2016
Start date
May 2011
Primary completion
Dec 2012
Completion
Apr 2014
Last update
Nov 16, 2016

Study contacts

Knut Mikkelsen, MD
study chair · Revmatismesykehuset AS, Lillehammer, Norway

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion